A Bioequivalence Trial of Dienogest in Healthy Chinese Participants Under Fed Conditions

This trial was a randomized, open‐label, single‐dose, 2‐treatment, 2‐period, crossover study to evaluate the pharmacokinetic (PK) profile, bioequivalence, and safety of test formulation and reference formulation of 2‐mg dienogest tablets in healthy Chinese participants. Eligible participants were ra...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical pharmacology in drug development 2024-02, Vol.13 (2), p.140-145
Hauptverfasser:	Zhao, Chunyan, Wang, Yuxia, Shao, Yanhua
Format:	Artikel
Sprache:	eng
Schlagworte:	Bioequivalence Biological Availability China Cross-Over Studies dienogest Female Humans Nandrolone - analogs & derivatives pharmacokinetics safety Therapeutic Equivalency
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!